PDR MEMBER LOGIN:
  • PDR Search

    Required field
  • Labeling Updates

    • K e y
    • BlackBox_opt Boxed Warning
    • Triangle_opt Other Warnings*
      *Warnings and Precautions; Adverse Reactions; Drug Interactions; and Contraindications
    • Circle_opt Updates to Indications/Dosage
    • Diamond_opt Other Updates
      Other labeling changes; added to PDR database
    Diamond_opt
    AndroGel 1.62% (testosterone)
    Circle_opt
    Diamond_opt
    Humira (adalimumab)
    Triangle_opt
    Diamond_opt
    Kaletra (lopinavir/ritonavir)
    Circle_opt
    Liletta SHI (levonorgestrel)
    Diamond_opt
    Triangle_opt
    Diamond_opt
    Triangle_opt
    Circle_opt
    Diamond_opt
    Orilissa (elagolix)
    Triangle_opt
    Circle_opt
    Diamond_opt
    Trokendi XR (topiramate)
    Triangle_opt
    Circle_opt
    Diamond_opt
    Venclexta (venetoclax)
  •  

    To have full prescribing information faxed or mailed to you, call 1-800-261-2313.

    The FDA encourages healthcare professionals to recognize and report misleading prescription drug advertising. To report: call 855-RX-BADAD (855-792-2323) or email BadAd@fda.gov. For more information, visit www.fda.gov.
    Report adverse events to MedWatch.